Stenotrophomonas maltophilia has emerged as a critical nosocomial opportunistic pathogen in the last few years. It is resistant to many clinically useful antibiotics; hence, new ways of combatting this bacterium are essential. Diffusible signal factor (DSF) dependent quorum sensing is a major mechanism of virulence induction in S. maltophilia, with RpfF playing a key role in DSF biosynthesis. Inhibiting S. maltophilia RpfF (SmRpfF) function via smallmolecule interference may constitute a new way of treating S. maltophilia infection. SmRpfF was therefore overexpressed in Escherichia coli, purified and crystallized using the hanging-drop vapour-diffusion method. The crystals belonged to the tetragonal space group P4 1 2 1 2 or P4 3 2 1 2, with unit-cell parameters a = b = 148.51, c = 122.82 Å , and diffracted to a resolution of 2.25 Å .
Introduction
Antibiotic resistance has developed against virtually every antibiotic employed (Clatworthy et al., 2007) . Recently, a new paradigm of targetting bacterial virulence factors rather than bacterial viability has been proposed (Zhang, 2003; Zhang & Dong, 2004; Raffa et al., 2005; Rasmussen & Givskov, 2006a,b; Bjarnsholt & Givskov, 2007; Clatworthy et al., 2007) . Since many opportunistic pathogenic bacteria rely on quorum sensing (QS) to regulate expression of their virulence factors, proteins involved in the QS signal network may serve as new targets for developing the next generation of drugs.
Stenotrophomonas maltophilia is a newly emerging bacterium that deserves much attention (Johnson & Duckworth, 2008; Looney et al., 2009) . The sequencing of its genome has recently been completed (Crossman et al., 2008) , revealing an organism with a remarkable capacity for drug and heavy-metal resistance. Similar to Xanthomonas campestris (Barber et al., 1997; Slater et al., 2000; Zhang & Dong, 2004; Ryan et al., 2006; Dong et al., 2007; He & Zhang, 2008) , S. maltophilia contains an rpf gene cluster (for regulator of pathogenicity factors) that is believed to be the major determinant for quorum sensing and for control of pathogenicity gene expression (Fouhy et al., 2007) . The rpf cluster comprises a number of rpf genes involved in regulating the synthesis of extracellular enzymes and polysaccharides. Of these rpf gene products, RpfF is the key protein responsible for diffusible signal factor (DSF) synthesis (Tang et al., 1991) . Importantly, mutation of the rpf F gene was found to significantly reduce the tolerance of S. maltophilia to many antimicrobial compounds, indicating that S. maltophilia RpfF (SmRpfF) is a potential target for the discovery of drugs based on this novel principle (Fouhy et al., 2007) .
However, in order to target RpfF it is necessary to obtain a more thorough understanding of its tertiary structure. Although RpfF has been found to bear some relatedness to enoyl-CoA hydratase, its structure is still unknown and remains to be determined. In this paper, we report the crystallization and preliminary X-ray diffraction characterization of SmRpfF.
Materials and methods

Cloning, expression and purification
The rpf F gene fragment was PCR-amplified directly from a local S. maltophilia genome with a forward 5 0 -TACTTCCAATCCAATG-CTATGTCTGCAGTACGCCCCATCA primer and a reverse 5 0 -TT ATCCACTTCCAATGTCAGGCCGGGTCGCCATT primer (the linker sequences are italicized). A ligation-independent cloning (LIC) approach (Aslanidis & de Jong, 1990 ) was carried out to obtain the desired construct according to a previously published protocol (Wu et al., 2005) . The final construct codes for an N-terminal His 6 tag, a 17-amino-acid linker and the SmRpfF target protein (289 amino acids) under the control of a T7 promoter. The vector was transformed into Escherichia coli BL21 (DE3) C41 host cells, which were grown in LB medium at 310 K until an OD 600 of 0.8 was attained. Overexpression of the His 6 -tagged target protein was induced by the addition of 0.5 mM IPTG at 293 K for 20 h. The cells were harvested, resuspended in equilibration buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl and 5 mM -mercaptoethanol) and lysed using a microfluidizer (Microfluidics). Most tagged target proteins were present in the soluble fraction (Fig. 1) . After centrifugation, the target protein was purified by immobilized metal-affinity chromatography (IMAC) on a nickel column (Sigma) and eluted with a 50-300 mM imidazole gradient in 20 mM Tris-HCl pH 8.0, 500 mM NaCl and 5 mM -mercaptoethanol. The fractions containing SmRpfF were monitored by SDS-PAGE, recombined and dialyzed repeatedly against 20 mM Tris-HCl pH 8.0, 500 mM NaCl and 5 mM -mercaptoethanol. After buffer exchange, the His 6 tag and linker were cleaved from SmRpfF by TEV (tobacco etch virus) protease at 295 K for 16 h and removed by immobilized metal-affinity chromatography (IMAC) on a nickel column (Sigma). For crystallization, SmRpfF was further purified by FPLC (Ä KTA, Pharmacia Inc.) on an anion-exchange column (DEAE Sepharose FF). The fractions eluted with 20 mM Tris pH 8.0, 1 M NaCl were combined and dialyzed against 20 mM Tris pH 8.0, 500 mM NaCl and 5 mM -mercaptoethanol. The final protein (292 amino acids) had greater than 95% purity and contained a nonnative tripeptide (Ser-Asn-Ala) followed by the target protein sequence of 289 amino acids (the GenBank accession No. for SmRpfF is DQ_4156711 and the protein ID is ABD594531). SeMetsubstituted SmRpfF was expressed in a similar way except that the cells were induced in SeMet-containing M9 minimal medium when an OD 600 of 0.8 was reached. The overexpression and purification of SeMet-substituted SmRpfF were monitored by SDS-PAGE as shown in Fig. 1. 
Crystallization
For crystallization, the protein was concentrated to 4 mg ml À1 in 20 mM Tris-HCl pH 8.0, 500 mM NaCl and 5 mM -mercaptoethanol using an Amicon Ultra-10 (Millipore). Screening for crystallization conditions of SmRpfF was performed using the sitting-drop vapourdiffusion method in 96-well plates (Hampton Research) at 298 K. 1 ml drops comprising equal volumes of protein solution and reservoir solution were equilibrated against 50 ml reservoir solution. Initial screens, including Hampton Research sparse-matrix Crystal Screens 1 and 2, a systematic PEG-pH screen and the PEG/Ion Screen, were performed using a Gilson C240 crystallization workstation. Diamondshaped crystals appeared in 3 d from a reservoir solution comprising 0.1 M sodium cacodylate buffer pH 6.5, 0.1 M NaH 2 PO 4 and 1 M sodium acetate. Crystals suitable for diffraction experiments were grown by mixing 1.5 ml protein solution with 1.5 ml reagent solution and equilibrating against 500 ml reservoir solution. The crystals reached maximum dimensions of 0.12 Â 0.07 Â 0.03 mm after one week (Fig. 2a) .
Data collection
The SmRpfF crystals were soaked in a cryoprotectant solution comprising reservoir solution plus 20%(v/v) glycerol. X-ray diffraction data were collected on National Synchrotron Radiation Research Center (NSRRC) beamline 13B1 in Taiwan. A native data set was collected to 2.25 Å resolution and a two-wavelength multiple anomalous dispersion (MAD) data set was collected to a resolution of 3.46 Å . The data were indexed and integrated using the HKL-2000 processing software (Otwinowski & Minor, 1997) , yielding three data sets, each 99% complete, with R merge values in the range 6.9-17.7%. The SmRpfF crystals belonged to the tetragonal space group P4 1 2 1 2 or P4 3 2 1 2, which cannot be discriminated until the final structure has been solved. The data-collection statistics are summarized in Table 1 and an X-ray diffraction image is shown in Fig. 2(b) .
Results and discussion
In this manuscript, we report the successful cloning, expression and crystallization of RpfF from S. maltophilia. We have also obtained high-resolution X-ray diffraction data from native crystals and moderate-resolution data from SeMet-substituted crystals of SmRpfF (Table 1 and Fig. 2) . Analyses of the diffraction intensities indicated that the space group was either P4 1 2 1 2 or P4 3 2 1 2, with unit-cell parameters a = b = 147.79, c = 122.04 Å . The Matthews coefficient V M (Matthews, 1968) suggested the presence of three, four or five SmRpfF protein molecules per asymmetric unit, with solvent contents of 63.64, 51.52 or 39.40%, respectively. There are a total of 12 methionine residues in SmRpfF. Their substitution by SeMet should provide sufficient phasing power to solve the SmRpfF structure. In fact, we have already obtained the preliminary Se substructure (data not shown). We are confident that we have the data required for structure solution and work towards solution is currently ongoing. 
